PerkinElmer, Inc. Announces Collaboration with Korea’s Sangmyung University for Drug Discovery Research

WALTHAM, Mass. & CHEONAN, South Korea--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has entered into a drug discovery research collaboration with Sangmyung University (Republic of Korea), based on applying PerkinElmer’s AequoScreen® aequorin assay technology to cutting-edge G-protein coupled receptor (GPCR) research.